BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

482 related articles for article (PubMed ID: 32232008)

  • 21. Bone microenvironment-mediated resistance of cancer cells to bisphosphonates and impact on bone osteocytes/stem cells.
    Alasmari A; Lin SC; Dibart S; Salih E
    Clin Exp Metastasis; 2016 Aug; 33(6):563-88. PubMed ID: 27155840
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular mechanisms of tumor-bone interactions in osteolytic metastases.
    Chirgwin JM; Guise TA
    Crit Rev Eukaryot Gene Expr; 2000; 10(2):159-78. PubMed ID: 11186331
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mesenchymal Stromal Cells: Emerging Roles in Bone Metastasis.
    Graham N; Qian BZ
    Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29642534
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Restoring Tissue Homeostasis at Metastatic Sites: A Focus on Extracellular Vesicles in Bone Metastasis.
    Giannandrea D; Citro V; Lesma E; Bignotto M; Platonova N; Chiaramonte R
    Front Oncol; 2021; 11():644109. PubMed ID: 33869035
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bisphosphonates for breast cancer.
    Pavlakis N; Schmidt R; Stockler M
    Cochrane Database Syst Rev; 2005 Jul; (3):CD003474. PubMed ID: 16034900
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular insights into the interplay between adiposity, breast cancer and bone metastasis.
    Soni S; Torvund M; Mandal CC
    Clin Exp Metastasis; 2021 Apr; 38(2):119-138. PubMed ID: 33591548
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The pathogenesis of bone metastasis in solid tumors: a review.
    Vičić I; Belev B
    Croat Med J; 2021 Jun; 62(3):270-282. PubMed ID: 34212564
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Notch2 pathway mediates breast cancer cellular dormancy and mobilisation in bone and contributes to haematopoietic stem cell mimicry.
    Capulli M; Hristova D; Valbret Z; Carys K; Arjan R; Maurizi A; Masedu F; Cappariello A; Rucci N; Teti A
    Br J Cancer; 2019 Jul; 121(2):157-171. PubMed ID: 31239543
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Understanding the Bone in Cancer Metastasis.
    Fornetti J; Welm AL; Stewart SA
    J Bone Miner Res; 2018 Dec; 33(12):2099-2113. PubMed ID: 30476357
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Breast cancer cells compete with hematopoietic stem and progenitor cells for intercellular adhesion molecule 1-mediated binding to the bone marrow microenvironment.
    Dhawan A; Friedrichs J; Bonin MV; Bejestani EP; Werner C; Wobus M; Chavakis T; Bornhäuser M
    Carcinogenesis; 2016 Aug; 37(8):759-767. PubMed ID: 27207667
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extracellular Vesicle-Packaged CDH11 and ITGA5 Induce the Premetastatic Niche for Bone Colonization of Breast Cancer Cells.
    Li XQ; Zhang R; Lu H; Yue XM; Huang YF
    Cancer Res; 2022 Apr; 82(8):1560-1574. PubMed ID: 35149589
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metastatic breast cancer cells overexpress and secrete miR-218 to regulate type I collagen deposition by osteoblasts.
    Liu X; Cao M; Palomares M; Wu X; Li A; Yan W; Fong MY; Chan WC; Wang SE
    Breast Cancer Res; 2018 Oct; 20(1):127. PubMed ID: 30348200
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Multiaspect Functions of Periostin in Tumor Progression.
    Liu Y; Huang Z; Cui D; Ouyang G
    Adv Exp Med Biol; 2019; 1132():125-136. PubMed ID: 31037631
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cancer Metastases to Bone: Concepts, Mechanisms, and Interactions with Bone Osteoblasts.
    Shupp AB; Kolb AD; Mukhopadhyay D; Bussard KM
    Cancers (Basel); 2018 Jun; 10(6):. PubMed ID: 29867053
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeting bone microenvironments for treatment and early detection of cancer bone metastatic niches.
    Yang H; Yu Z; Ji S; Huo Q; Yan J; Gao Y; Niu Y; Xu M; Liu Y
    J Control Release; 2022 Jan; 341():443-456. PubMed ID: 34748870
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fibroblast growth factor 2 supports osteoblastic niche cells during hematopoietic homeostasis recovery after bone marrow suppression.
    Yoon KA; Son Y; Choi YJ; Kim JH; Cho JY
    Cell Commun Signal; 2017 Jun; 15(1):25. PubMed ID: 28662672
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modeling the breast cancer bone metastatic niche in complex three-dimensional cocultures.
    Marlow R; Dontu G
    Methods Mol Biol; 2015; 1293():213-20. PubMed ID: 26040690
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Breast cancer-derived factors facilitate osteolytic bone metastasis.
    Rose AA; Siegel PM
    Bull Cancer; 2006 Sep; 93(9):931-43. PubMed ID: 16980236
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preclinical studies with zoledronic acid and other bisphosphonates: impact on the bone microenvironment.
    Mundy GR; Yoneda T; Hiraga T
    Semin Oncol; 2001 Apr; 28(2 Suppl 6):35-44. PubMed ID: 11346863
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The molecular signature of the stroma response in prostate cancer-induced osteoblastic bone metastasis highlights expansion of hematopoietic and prostate epithelial stem cell niches.
    Özdemir BC; Hensel J; Secondini C; Wetterwald A; Schwaninger R; Fleischmann A; Raffelsberger W; Poch O; Delorenzi M; Temanni R; Mills IG; van der Pluijm G; Thalmann GN; Cecchini MG
    PLoS One; 2014; 9(12):e114530. PubMed ID: 25485970
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.